SOLAR SENSE ZANY ZINC SPF 50 WHITE - oxide cream USA - engelska - NLM (National Library of Medicine)

solar sense zany zinc spf 50 white - oxide cream

cca industries, inc. - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide 25 g in 100 g

SOLAR SENSE ZANY ZINC SPF 50 GREEN - oxide cream USA - engelska - NLM (National Library of Medicine)

solar sense zany zinc spf 50 green - oxide cream

cca industries, inc. - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide 25 g in 100 g

SOLAR SENSE SUN DAMAGE RESTORATION BODY SPF 15 zinc oxide octinoxate lotion USA - engelska - NLM (National Library of Medicine)

solar sense sun damage restoration body spf 15 zinc oxide octinoxate lotion

cca industries, inc - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide 2 ml in 100 ml

SOLAR SENSE ZANY ZINC SPF 50 BLUE - oxide cream USA - engelska - NLM (National Library of Medicine)

solar sense zany zinc spf 50 blue - oxide cream

cca industries, inc - zinc oxide (unii: soi2loh54z) (zinc - unii:j41csq7qds) - zinc oxide 25 g in 100 g

SOLAR SENSE ZANY ZINC SPF 50 YELLOW - oxide cream USA - engelska - NLM (National Library of Medicine)

solar sense zany zinc spf 50 yellow - oxide cream

cca industries, inc - zinc oxide (unii: soi2loh54z) (zinc - unii:j41csq7qds) - zinc oxide 25 g in 100 g

SOLAR SENSE ZANY ZINC SPF 50 PINK - oxide cream USA - engelska - NLM (National Library of Medicine)

solar sense zany zinc spf 50 pink - oxide cream

cca industries, inc - zinc oxide (unii: soi2loh54z) (zinc - unii:j41csq7qds) - zinc oxide 25 g in 100 g

Menjugate 10 micrograms suspension for injection Meningococcal group C conjugate vaccine Irland - engelska - HPRA (Health Products Regulatory Authority)

menjugate 10 micrograms suspension for injection meningococcal group c conjugate vaccine

gsk vaccines s.r.l. - meningococcal group c oligosaccharide; corynebacterium diphtheriae crm197 protein - suspension for injection in pre-filled syringe - 10 - meningococcal vaccines; other meningococcal polyvalent purified polysaccharides antigen - meningococcal vaccines - active immunisation of children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by neisseria meningitidis group c.

SUDDEN CHANGE INTENSIVE RESTORATION DAILY MOISTURIZER SPF 15 zinc oxide octinoxate cream USA - engelska - NLM (National Library of Medicine)

sudden change intensive restoration daily moisturizer spf 15 zinc oxide octinoxate cream

cca industries inc - zinc oxide 2.00%..............................sunscreen octinoxate 6.00%............................sunscreen -

SOLAR SENSE SPF 45 FOR FACE, NOSE AND LIPS CREAM Kanada - engelska - Health Canada

solar sense spf 45 for face, nose and lips cream

cca industries, inc. - zinc oxide; octinoxate; oxybenzone - cream - 6.65%; 7.5%; 4% - zinc oxide 6.65%; octinoxate 7.5%; oxybenzone 4% - sunscreen agents

PNEUMOVAX 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5mL injection pre-filled syringe Australien - engelska - Department of Health (Therapeutic Goods Administration)

pneumovax 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5ml injection pre-filled syringe

merck sharp & dohme (australia) pty ltd - pneumococcal purified capsular polysaccharides, quantity: 50 microgram/ml - injection, solution - excipient ingredients: water for injections; phenol; sodium chloride - pneumovax 23 is indicated for immunisation of individuals in the following situations: all individuals over the age of 65 years; individuals with asplenia, either functional or anatomical, including sickle cell disease, in persons more than 2 years of age; where possible the vaccine should be given at least 14 days before splenectomy; immunocompromised patients at increased risk of pneumococcal disease (eg patients with hiv infection before the development of aids, nephrotic syndrome, multiple myeloma, lymphoma, hodgkin's disease and organ transplantation); aboriginal and torres strait islander people over 50 years of age; immunocompetent persons at increased risk of complications from pneumococcal disease because of chronic illness (eg chronic cardiac, renal or pulmonary disease, diabetes mellitus, alcoholism and cirrhosis); patients with cerebrospinal fluid leaks. in australia, the national health and medical research council (nhmrc) currently recommends the vaccination of tobacco smokers with the 23-valent polysaccharide pneumococcal vaccine. pneumovax 23 is indicated for immunisation only against pneumococcal disease caused by those pneumococcal types included in the vaccine. effectiveness of the vaccine in the prevention of pneumococcal pneumonia and pneumococcal bacteremia has been demonstrated. in australia, the national health and medical research council (nhmrc) currently recommeds the vaccination of tabacco smokers with the 23-valent polysaccharide pneumococcal vaccine. pneumovax 23 will not prevent disease caused by capsular types of pneumococcus othar those contained in the vaccine.